GC Therapeutics
PrivateLast Round
Series A
Sep 19, 2024
Total Funding Raised
$85M
Company Overview
GC Therapeutics is a biotechnology company that specializes in programming patient-derived stem cells into various cell types using an innovative platform that combines synthetic biology and artificial intelligence to create advanced cell therapies with enhanced manufacturing efficiency and quality.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GC Therapeutics Comparables
Compare GC Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Syntax Bio | 88% | |
| Trailhead Biosystems Inc. | 82% | |
| Mogrify | 82% |
GC Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 19, 2024 |
GC Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A, Seed |
| Cormorant Asset Management | Series A |
| Gaingels | Series A |
| Global Brain Corporation | Series A |
| Medical Excellence Capital | Series A |
| Pear VC | Series A |
| Mubadala Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2026
Kate Haviland appointed as new board chair.
- Apr 1, 2025
Proprietary TFome™ platform developed in Professor George Church's lab.
GC Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GC Therapeutics's valuation, stock price, and market status.
Is GCTx a public or private company?
GCTx is a private company.
What is the current stock price of GCTx?
GCTx is a private company with no public stock price. No recent secondary market data is available.
How much is GCTx worth (valuation)?
Valuation information for GCTx is not publicly available.
Can I buy GCTx stock?
GCTx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GCTx's last funding round?
GCTx's most recent funding round was Series A on September 19, 2024.
Who are the main investors in GCTx?
Key investors in GCTx include Cormorant Asset Management.
Will GCTx IPO soon?
No public IPO plans have been announced for GCTx.
How can I track GCTx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GCTx's secondary market activity and sign up for updates.